May 17, 2007 — /PRNewswire/ — EAST RUTHERFORD, NJ — The organizers of the annual Pharma ChemOutsourcing Conference and Exhibition are pleased to announce the 2007 event featuring 80 industry speakers from a diverse group of pharmaceutical and biotech companies for the September 10-11 show in New Jersey.

The conference focuses exclusively on sourcing/outsourcing pharmaceutical chemistry topics and attracts 400-500 industry attendees from around the world. A large exhibition adds a strong business development flavor to the information and networking intensive event. The show was recently relocated to the Sheraton Conference in East Rutherford, NJ, to accommodate the larger than expected gathering.

The 2007 Keynotes are:

• “When Will The Pharmaceutical Custom Chemistry Services Industry Reach Equilibrium?” — Stefan Loren, Ph.D., Vice President, Perceptive Life Sciences
• “API/Chemical Intermediate Outsourcing – A Pharma Perspective” — Laurie Chipperfield, Director, API Strategic Sourcing & Planning, Pfizer
• “How Well Equipped Is The Service Provider Community To Handle The Transition From Clinical Development to Commercial?” — Ioannis I. Valvis, Associate Director Sourcing Strategy, Bristol-Myers Squibb
• “A View of the Indian Pharmaceutical R & D Support Services: How Is It Evolving?” — David Floyd, Ph.D., CSO, Pharmacopeia

The chemistry sourcing industry changes noticeably from year to year thus the conference provides an up-to-date examination from Discovery through Commercial, with much of the discussion centered on pre-clinical R & D. The major geo-regions in Asia, North America, and Europe are well addressed as are the increasingly complex relationships that have developed among pharmaceutical companies and CRO/CMOs.

In 2007 the conference covers in depth the unique sourcing needs of “Emerging” pharmaceutical companies whose small size makes such relationships with custom synthesis providers especially important, reports Mark Alexay of Apaporis, the event organizer.

The speaking faculty includes representatives from most of “Big Pharma” and also from many biotechs such as Poniard Pharmaceuticals, Plexxicon, Sapphire Therapeutics, Exelixis, Lexicon Pharmaceuticals, Cephalon, Sepracor, GPC Biotech, EntreMed, and AtheroGenics. Chemistry suppliers contributors from InterChem, ChemDiv, Albemarle, CiVentiChem, Wilmington Pharma Tech, Chembiotek, Ricerca, NAEJA, Dr Reddy’s, IQSynthesis, and Ash Stevens round out the speaking roster.

The show is studded with networking and socializing events throughout to foster interface among the many delegates. Activities are show related and many attendees staying in the area for longer periods visit New York City.

The conference agenda and related information is available at www.chemoutsourcing.com. Some speaking opportunities still remain and exhibitors may still secure optimal space. Contact the organizers directly; Mark Alexay at [email protected]/201.452.4023 or Amy Yueh at [email protected]/212.228.7974

Source: Apaporis LLC

Contact:
Mark Alexay, +1-201-452-4023, [email protected], or Amy Yueh, +1-212-228-7974, [email protected]

Web site: http://www.chemoutsourcing.com/